Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia | Synapse

February 25, 2025Open Access

Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia

IKInder KaulBristol-Myers Squibb (Germany)ACAmy ClaxtonBristol-Myers Squibb (Germany)SSSharon SawchakBristol-Myers Squibb (Germany)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Trial Registration: ClinicalTrials.gov identifiers: NCT03697252, NCT04659161, NCT04738123.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Kaul et al. (Tue,) studied this question.

synapsesocial.com/papers/69daa2218988aeabbe687072 https://doi.org/https://doi.org/10.4088/jcp.24m15497

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo